Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Turkey’s intel chief lays out country’s vision for Middle East, world - 2Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
- 3The Development of Shipping: Controlling Towards a More Associated Future
- 4We may be witnessing the messy death of a star in real time
- 5Mojtaba Khamenei unconscious in Qom, not actually running Iran
- Pick the Ideal Family Feline Variety for Your Home
- The secret appeal of Harlan Coben’s messy, addictive TV thrillers
- Venezuelan President Maduro arrives in New York following U.S. capture: Full coverage
- Top Frozen yogurt Flavor: Cast Your Vote!
- UN chief warns he could refer Israel to ICJ over laws targetting UNRWA
- 2 new malaria treatments announced as drug resistance grows
- Indoor Drinking Fountains: Famous Home Advancements during the Pandemic
- Artemis 2 astronauts head for the moon after make-or-break engine burn (video)
- Manual for Tracking down the Mysterious Cascades in China
